HomeInvestingTechnical AnalysisEmbecta (EMBC) CEO on Diabetes Treatment Market
00:00
00:00
06:49
Embecta (EMBC) CEO on Diabetes Treatment Market

Embecta (EMBC) CEO on Diabetes Treatment Market

Embecta (EMBC) CEO Dev Kurdikar joins Oliver Renick to give an overview of the company and discuss its 2Q earnings. He also talks about the impact of GLP-1 drugs. He then goes over the diabetes treatment market, as well as other emerging markets. Tune in to find out more about the stock market today.

Market On Close

17 May 2024

SHARE

ON AIR
11:00 am
Gamma On
replay
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:00 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
ON AIR
11:00 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
education
1:00 pm
Inside the Mind of a Trader
REPLAY
education
1:30 pm
Inside the Mind of a Trader
REPLAY
education
2:00 pm
Inside the Mind of a Trader
REPLAY
2:30 pm
Market Overtime
REPLAY
3:00 pm
Gamma On
REPLAY
3:30 pm
Gamma On
REPLAY
4:00 pm
Gamma On
REPLAY
4:30 pm
Gamma On
REPLAY
5:30 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
6:30 pm
Gamma On
REPLAY
7:00 pm
Gamma On
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Gamma On
REPLAY
education
10:00 pm
Your First Trade
REPLAY
education
10:30 pm
Your First Trade
REPLAY
education
11:00 pm
Your First Trade
REPLAY
education
11:30 pm
Your First Trade
REPLAY
education
12:00 am
Your First Trade
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Gamma On
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY

Get the Market Minute

Daily insights for every investor